Marshall Wace, LLP Oric Pharmaceuticals, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 47,695 shares of ORIC stock, worth $407,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,695Holding current value
$407,315% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$56.1 Million0.12% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$45.1 Million6.85% of portfolio
-
Nextech Invest Ag5.29MShares$45.1 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$41.3 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$34.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $338M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...